- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Hyperkalaemia
- Meeting Date: November 2022
- Public Summary Document (PSD) November 2022 PBAC Meeting - (PDF 1MB)
- Public Summary Document (PSD) November 2022 PBAC Meeting - (Word 369KB)
Patiromer – November 2022
Patiromer: Sachet, 8.4 g powder for oral liquid, Sachet, 16.8 g powder for oral liquid; Veltassa®
Last updated
3 March 2023